Health CareDx Receives CE Mark for AlloSeq HCT for Use in Hematopoietic Cell Transplantation James Pereira May 24, 2022 SOUTH SAN FRANCISCO, Calif., May 24, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™… Read More...
Health Motixafortide Prior to HCT Shows Benefit in Multiple Myeloma James Pereira Jan 6, 2022 At the American Society of Hematology… Read More...